HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Previous close
$0.0050
Day range
$0.0050 - $0.0050
Year range
$0.0038 - $0.031
Market cap
11.34M AUD
Avg Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.78M | -49.37% |
Operating expense | 4.11M | -10.84% |
Net income | -1.43M | -216.94% |
Net profit margin | -51.46 | -330.97% |
Earnings per share | — | — |
EBITDA | -1.09M | -196.88% |
Effective tax rate | -5.07% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.07M | 43.76% |
Total assets | 18.68M | -30.02% |
Total liabilities | 12.74M | -0.69% |
Total equity | 5.94M | — |
Shares outstanding | 1.58B | — |
Price to book | ∞ | — |
Return on assets | -17.81% | — |
Return on capital | -55.99% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.43M | -216.94% |
Cash from operations | -1.32M | 43.40% |
Cash from investing | 12.97K | 10.74% |
Cash from financing | 2.29M | -21.82% |
Net change in cash | 1.01M | 73.30% |
Free cash flow | -264.26K | -134.62% |
About
Founded
2020
Website
